Risikoanalyse er endnu ikke tilgængelig for dette lands udbud. Understøttede lande i øjeblikket: Estland, Polen, Litauen og Letland.
Få en AI-drevet vinderstrategi skræddersyet til dette udbud. Inkluderer sandsynlighedsscore for at vinde, vigtige muligheder og udfordringer, anbefalede fokusområder for tilbuddet, indsigt i konkurrencepositionering og handlingsrettede anbefalinger for at maksimere dine chancer.
Log indOpgrader for at se, hvilke virksomheder der sandsynligvis vil afgive tilbud på dette udbud, baseret på historiske indkøbsdata.
Log ind9 krav på tværs af 5 kategorier
Tilmeld dig for at se komplette krav og analyser
4 dokumenter tilgængelige med AI-resuméer
This notice invites suppliers to participate in voluntary preliminary market engagement for a potential £3 billion, 8-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.
This document is an OCDS release package detailing a preliminary market engagement by NHS Supply Chain for a potential £3 billion framework agreement over eight years for insulin pumps, continuous glucose monitoring devices, and related diabetes technologies.
This notice invites suppliers to participate in preliminary market engagement for a potential £3 billion, eight-year framework agreement for insulin pumps, continuous glucose monitoring devices, and associated diabetes technologies for NHS Supply Chain.
Tilmeld dig for at se dokumentresuméer og analyser
This is a well-structured preliminary market engagement notice for a significant framework agreement. While it lacks formal tender elements like evaluation criteria and e-submission, this is appropriate for its 'planning' status and PME nature.
The notice clearly defines itself as a preliminary market engagement (PME) and references the UK Procurement Act 2023, indicating compliance with national regulations for this stage. The CPV code is appropriate, and there are no disputes or suspensions.
The description is very clear and unambiguous, explaining the purpose, scope, and potential duration/value of the future framework agreement. The requirements, as extracted, are clear within the context of a PME.
Basic information (title, reference, organization, value, duration) is present. Requirements for PME participation are defined. However, one document failed to download, which is a minor completeness issue.
The PME is explicitly open and voluntary, indicating a fair approach to market engagement. Requirements are generic and not tailored. The absence of e-submission is a minor drawback for equal access.
The lack of e-submission functionality is a significant practical drawback for participation. Other practical details like contract start date and duration are clearly specified.
Data is largely consistent and logical, with dates aligning appropriately. The estimated values in GBP and EUR are roughly consistent. The 'Liable Person' field is empty, which is a minor inconsistency.
The notice explicitly mentions 'encouraging openness to innovation' and 'advanced diabetes technologies,' which is a positive. However, there are no explicit green procurement or social criteria mentioned.
Tilmeld dig for at se komplette krav og analyser
Intet kreditkort krævet • Opsætning på 2 minutter
Vores udbudseksperter forbereder alt. Det virker – du gennemgår, godkender og indsender.
Hej! Jeg er din AI-assistent for dette udbud. Jeg kan hjælpe dig med at forstå krav, frister, berettigelseskriterier og give strategiske indsigter.
Intet kreditkort krævet